Lindbrook Capital, LLC Galapagos Nv Transaction History
Lindbrook Capital, LLC
- $1.18 Billion
- Q3 2024
A detailed history of Lindbrook Capital, LLC transactions in Galapagos Nv stock. As of the latest transaction made, Lindbrook Capital, LLC holds 593 shares of GLPG stock, worth $16,188. This represents 0.0% of its overall portfolio holdings.
Number of Shares
593
Previous 1,101
46.14%
Holding current value
$16,188
Previous $27,000
37.04%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding GLPG
# of Institutions
85Shares Held
12.3MCall Options Held
69.1KPut Options Held
42.7K-
Bvf Inc San Francisco, CA1.57MShares$42.8 Million1.44% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY1.41MShares$38.5 Million0.76% of portfolio
-
Prosight Management, LP Dallas, TX1.03MShares$28.1 Million7.95% of portfolio
-
Logos Global Management LP San Francisco, CA800KShares$21.8 Million3.05% of portfolio
-
Primecap Management CO Pasadena, CA720KShares$19.7 Million0.02% of portfolio
About GALAPAGOS NV
- Ticker GLPG
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,835,500
- Market Cap $1.8B
- Description
- Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...